Search
for
Sort by
Research 271–300 of 367
- Transcriptomic characterization of Lonrf1 at the single-cell level under pathophysiological conditions
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Different Ligands of the TRPV3 Cation Channel Cause Distinct Conformational Changes as Revealed by Intrinsic Tryptophan Fluorescence Quenching
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- A Hairy Cituation – PADIs in Regeneration and Alopecia
- TMT-Based Proteomic Explores the Influence of DHEA on the Osteogenic Differentiation of hBMSCs
- Pubertal hormones increase hippocampal expression of α4βδ GABAA receptors
- Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Melatonin increases growth properties in human dermal papilla spheroids by activating AKT/GSK3β/β-Catenin signaling pathway
- The connection of 5-alpha reductase inhibitors to the development of depression
- Mitochondrial dysfunction in diabetic neuropathy may be involved in the development of neuropathic pain via a reduction in neurosteroid synthesis
- Levels of extracellular ATP in growth zones of Arabidopsis primary roots are changed by altered expression of apyrase enzymes
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- The role of glucose metabolism in wound healing: an overview
- Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation
- Biochemical Insights and Clinical Applications of Ischemia-Modified Albumin in Ischemic Conditions
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Pyruvate Kinase M2 Role in Cardiovascular Repair
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- TRPV3 Ion Channel: From Gene to Pharmacology
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- Pyruvate Kinase M2 Promotes Hair Regeneration by Connecting Metabolic and Wnt/β-Catenin Signaling
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- PSAT1 regulates hair follicle growth and stem cell behavior in cashmere goats
- Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases